This Book Only Covers Solid Tumors
-
A growth that can be non-cancerous or cancerous develops from tissues without fluid areas. Examples include cancers like lung, prostate, breast, and colon carcinomas, as well as tumors from soft tissues and bones like leiomyosarcoma, liposarcoma, chondrosarcoma, and osteosarcoma. Cancers originating from blood or bone marrow, such as leukemias and myeloproliferative disorders, are not classified as solid tumors.
-
- Surgery: Removing the tumor and surrounding tissue.
- Chemotherapy: Using drugs to eliminate or slow down cancer cells.
- Radiation therapy: Using high-energy rays to destroy cancer cells.
- Immunotherapy: Boosting the immune system to fight cancer.
- Targeted therapy: Medications that target specific genes or proteins involved in cancer growth.
- Tumor Ablation: Using heat or cold to eliminate the tumor.
- Photodynamic Therapy (PDT): Using a photosensitizing agent and light to destroy cancer cells.
- Combination Therapy: Using multiple treatments like surgery, chemotherapy, and radiation therapy together to target the tumor from different angles and improve treatment outcomes.
- Intratumoral injection is another treatment approach for solid tumors. This method involves directly injecting medication into the tumor to target and treat cancer cells within the tumor mass. Intratumoral injections can deliver chemotherapy, immunotherapy, or other medications directly to the tumor site, offering a localized and targeted treatment option for certain types of solid tumors.
I strongly recommend that cancer patients with no other treatment options perform intratumoral injections of chlorine dioxide at home to ablate some tumors.
⋆To understand the reasons, please browse this website thoroughly.
I strongly recommend that cancer patients with no other treatment options perform intratumoral injections of chlorine dioxide at home to ablate some tumors.
⋆To understand the reasons, please browse this website thoroughly.
Preventing Early Deaths in Cancer Patients from Fear and Overtreatment
"Of those who die from cancer, one-third are scared to death, one-third are treated to death, and only the remaining third actually die from the cancer itself."
“You don't need to invent anything new, but combine all parts correctly, and you can create something valuable.”
The Current Plight in Cancer Care
Advanced Medical Technology's Limited Outcome
For cancer patients in the U.S., despite advanced medical care, ample health insurance, and cutting-edge anti-cancer treatments, their survival may not surpass that of patients in China using cost-effective medications.
The Chaos of Overtreatment
In cancer research, complex technologies lead to overtreatment in clinical diagnosis. Doctors prioritize short-term effective treatments, neglecting long-term negative impacts like side effects, drug resistance, and unsustainable therapies.
Patients' Continuous Dissatisfaction
Limited patient involvement in cancer treatment hinders treatment effectiveness by undermining informed decision-making and overlooking patient perspectives, leading to suboptimal treatment outcomes.
Cause
Physician Factors
Tendency to overtreat under standard treatment protocols. Significant decision-making power, but treatment choices are random. Long-term patient benefits are often overlooked in treatment decisions.
Healthcare System Factors:
Treatment plans do not target long-term patient benefits. Standard treatments limit individual choices. Strict regulations hinder innovation.
Traditional Views Factors:
Early detection and treatment lead to overtreatment. Advanced technologies do not necessarily yield long-term effects. High mortality rates undermine patient confidence.
Patient Factors
Patients seldom participate in decision-making, overlooking true goals. Fear of cancer impedes clear understanding. Lack of proper standards for evaluating treatment options. Patients must change their mindset and learn new ways of thinking to improve their cancer treatment outcomes.
Why Introduce First Principles
Applying First Principles to Innovate Cancer Treatment Approaches
5-Factor Assessment Framework
-
Inhibition Rate
The significance of inhibition rate in cancer treatment lies in therapies that combine direct cancer cell elimination and immune system activation for effective treatment.
-
Safety
The importance of safety in cancer treatment is highlighted, emphasizing the need for therapies with fewer side effects and higher safety levels to enhance patient outcomes.
-
Drug Resistance
In discussing drug resistance in cancer treatment, we focus on targeting specific mutations and the evolution of resistance. We stress balancing short-term tumor control with long-term patient well-being, proposing a reevaluation of treatment strategies to minimize resistance and improve outcomes.
-
Sustainability
The sustainability of cancer treatment is vital, focusing on consistently killing cancer cells, reducing cancer burden, and prolonging life. Safety, drug resistance, and surgical removal impact sustainability. Patients should prioritize sustainable treatments for long-term benefits.
-
Convenience
We value convenience in healthcare decisions, considering its influence on treatment choices and patient preferences. Patients should weigh convenience with other factors for informed decisions.
Steps for Selecting Current Cancer Therapies in the NCCN Guidelines Using the 5-Factor Assessment Framework
Applying First Principles to Innovate Cancer Treatment Approaches
Innovative Combination Therapies:
We have revolutionized the analysis model and evaluation framework for cancer treatment by adhering to core principles. Our innovation goes beyond traditional cancer treatments outlined in the NCCN guidelines, focusing on the selection process and integrating cutting-edge therapies.
Transition from Systemic Medication to Intratumoral Injection:
While integrating groundbreaking cancer treatments presents challenges within the current healthcare landscape, our strategic thinking methodology envisions enhanced possibilities for cancer treatment. The shift from systemic medication to intratumoral injection marks a progressive move towards personalized and targeted therapies.
Development Directions of Intratumoral Injection Drugs
Utilizing the Five-Factor Assessment Framework grounded in fundamental principles, we foresee the future path of innovative cancer therapies. The development directions of intratumoral injection drugs represent a logical progression, offering promising avenues for more effective and precise cancer treatments.
Reading this Book: Advice You Will Receive
You can easily extend your high-quality survival period by simply reassessing and selecting the treatment methods recommended by doctors, without the need for complex treatment techniques.
—
Choosing sustainable therapies to keep cancer cells at a lower level rather than aiming for 100% eradication can help avoid excessive treatment in most cases.
—
Do not regret missing the "early detection and treatment" window. Instead, be grateful for avoiding fear and overtreatment. You have plenty of time to reassemble existing cancer therapies for better outcomes.
—
Surgery is not always the primary consideration for treatment. The long-term side effects of surgery are often overlooked, and surgery is not a sustainable treatment method.
—
It is important not to blindly trust the cancer treatment standards in developed countries, as they often serve as showcases for expensive costs and complex technologies.
—
It's important not to blindly trust clinical guidelines and the authority of doctors. No one cares more about your long-term well-being than yourself. You are always the primary decision-maker in your cancer journey.
—
Confronting the Cancer Care Plight: Using First Principles to Navigate Your Cancer Journey
On Sale
$10.00
$10.00